This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Other. Active years: 2008-2014.
Company Filing History:
1 out of 1,327 
1 out of 834,307 Years Active: 2008-2014
Title: Michael Dittrich: Innovator in Cytotoxic Polypeptides
Introduction
Michael Dittrich is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of cytotoxic polypeptides. With a total of 2 patents, Dittrich's work has garnered attention in scientific communities.
Latest Patents
His latest patents include a cytotoxic polypeptide that is an L-amino acid oxidase isolated from the ink of the sea hare. This innovative approach highlights the potential applications of natural compounds in therapeutic settings.
Career Highlights
Throughout his career, Dittrich has been associated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. This prestigious institution has provided a platform for his research and development efforts.
Collaborations
Michael Dittrich has collaborated with notable colleagues such as Daniel Butzke and Sigrid Goedert. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Michael Dittrich's work in the field of cytotoxic polypeptides showcases his innovative spirit and dedication to scientific advancement. His contributions continue to influence the biotechnology landscape.